Taro Pharmaceutical Industries (TARO) Financials

TARO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.2 billion 384.1 million
2023-09-30 2.1 billion 371.9 million
2023-06-30 2.1 billion 396.5 million
2023-03-31 2.1 billion 404.7 million

TARO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.6 million ?
2023-09-30 40.5 million ?
2023-06-30 933000 ?
2023-03-31 48.1 million ?

TARO Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 20.2 million
2023-09-30 8.5 million
2023-06-30 10.0 million
2023-03-31 6.9 million

TARO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 902.2 million - -
2023-09-30 907.0 million - -
2023-06-30 806.2 million - -
2023-03-31 850.3 million - 2.0 million

TARO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 37.6 million
2023-09-30 37.6 million
2023-06-30 37.6 million
2023-03-31 37.6 million

TARO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 34.5 million 13.6 million 50.4 million -
2023-09-30 7.0 million 14.3 million 54.5 million -
2023-06-30 6.8 million 16.1 million 55.9 million -
2023-03-31 8.5 million 16.3 million 35.6 million 14.5 million

TARO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 157.1 million 77.3 million
2023-09-30 148.2 million 74.6 million
2023-06-30 158.9 million 94.8 million
2023-03-31 146.6 million 70.9 million

TARO

Price: $42.45

52 week price:
23.92
45.76

Earnings Per Share: 1.22 USD

P/E Ratio: 34.98

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 10328

Ebitda: 458.4 million

Market Capitalization: 1.6 billion

Links: